Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: compulsory licensing for export
BMJ Commentary: Overriding drug and medical technology patents for pandemic recovery:...
Medicines Law & Policy
-
April 13, 2021
Never say never – Why the High Income Countries that opted-out...
Christopher Garrison
-
April 8, 2020
New Database Documents the Power of TRIPS Flexibilities
Ellen 't Hoen
-
November 27, 2018
European Pharmaceutical Legislation Needs Exceptions to Data and Market Exclusivity to...
Ellen 't Hoen
-
May 21, 2018
Access to medicines amendment of the WTO TRIPS Agreement. Hype or...
Ellen 't Hoen
-
April 11, 2017